Trademark: 86965116
Word
QUIVADLA
Status
Dead
Status Code
606
Status Date
Monday, April 15, 2019
Serial Number
86965116
Mark Type
4000
Filing Date
Tuesday, April 5, 2016
Published for Opposition
Tuesday, July 17, 2018
Abandoned Date
Monday, April 15, 2019

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Trademark Events
Apr 15, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 15, 2019
Abandonment - No Use Statement Filed
Sep 11, 2018
Noa E-Mailed - Sou Required From Applicant
Jul 17, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2018
Published For Opposition
Jun 27, 2018
Notification Of Notice Of Publication E-Mailed
Jun 13, 2018
Approved For Pub - Principal Register
Dec 9, 2017
Report Completed Suspension Check Case Still Suspended
Jun 9, 2017
Report Completed Suspension Check Case Still Suspended
Dec 8, 2016
Notification Of Letter Of Suspension E-Mailed
Dec 8, 2016
Letter Of Suspension E-Mailed
Dec 8, 2016
Suspension Letter Written
Jun 8, 2016
Notification Of Letter Of Suspension E-Mailed
Jun 8, 2016
Letter Of Suspension E-Mailed
Jun 8, 2016
Suspension Letter Written
Jun 7, 2016
Assigned To Examiner
Apr 11, 2016
New Application Office Supplied Data Entered In Tram
Apr 8, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24